These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 186655)

  • 21. Bacille Calmette-Guérin infection in the mouse. Regulation of macrophage plasminogen activator by T lymphocytes and specific antigen.
    Gordon S; Cohn ZA
    J Exp Med; 1978 Apr; 147(4):1175-88. PubMed ID: 349108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
    Bonventre PF; Straus D; Baughn RE; Imhoff J
    J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular responses and Mycobacterium bovis BCG growth inhibition by bovine lymphocytes.
    Carpenter E; Fray L; Gormley E
    Immunol Cell Biol; 1997 Dec; 75(6):554-60. PubMed ID: 9492191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic lymphoid cells and antibodies from guinea pigs immunized with tubercle bacilli.
    Wasserman J; Packalén T; Perlmann P; Perlmann H
    Int Arch Allergy Appl Immunol; 1969; 36(1):115-6. PubMed ID: 4980285
    [No Abstract]   [Full Text] [Related]  

  • 25. IN VITRO STUDIES ON THE INTERACTIONS BETWEEN MACROPHAGES OF RABBITS AND TUBERCLE BACILLI. II. CELLULAR AND HUMORAL ASPECTS OF ACQUIRED RESISTANCE.
    HSU HS
    Am Rev Respir Dis; 1965 Apr; 91():499-509. PubMed ID: 14263929
    [No Abstract]   [Full Text] [Related]  

  • 26. Mycobacterial proliferation in macrophages is prevented by incubation with lymphocytes activated in vitro with a mycobacterial antigen complex.
    Beschin A; Brijs L; De Baetselier P; Cocito C
    Eur J Immunol; 1991 Mar; 21(3):793-7. PubMed ID: 2009916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of macrophages by products of lymphocytes from normal and syphilitic rabbits.
    Lukehart SA
    Infect Immun; 1982 Jul; 37(1):64-9. PubMed ID: 7049954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of lymphocyte supernatant fluids on the intracellular growth of virulent tubercle bacilli.
    Klun CL; Youmans GP
    J Reticuloendothel Soc; 1973 Mar; 13(3):263-74. PubMed ID: 4196702
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigen-specific lymphocytes enhance nitric oxide production in Mycobacterium bovis BCG-infected bovine macrophages.
    Carpenter E; Fray L; Gormley E
    Immunol Cell Biol; 1998 Aug; 76(4):363-8. PubMed ID: 9723778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Destruction of syngeneic tumors by tuberculin-stimulated peritoneal exudate cells from guinea pigs immunized to Mycobacterium bovis (strain BCG).
    Zwilling BS; Leonard EJ; Bast RC; Zbar B
    J Natl Cancer Inst; 1974 Aug; 53(2):541-6. PubMed ID: 4367248
    [No Abstract]   [Full Text] [Related]  

  • 31. Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells.
    Churchill WH; Piessens WF; Sulis CA; David JR
    J Immunol; 1975 Sep; 115(3):781-6. PubMed ID: 50373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune interferon. I. Production by lymphokine-activated murine macrophages.
    Neumann C; Sorg C
    Eur J Immunol; 1977 Oct; 7(10):719-25. PubMed ID: 338310
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis.
    Roberts AD; Sonnenberg MG; Ordway DJ; Furney SK; Brennan PJ; Belisle JT; Orme IM
    Immunology; 1995 Jul; 85(3):502-8. PubMed ID: 7558141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation between delayed skin reactivity and macrophage migration inhibition or lymphocyte transformation in tuberculin-type hypersensitivity and Jones-Mote hypersensitivity.
    Himeno K; Nomoto K; Kuroiwa A; Miyazaki S; Takeya K
    Microbiol Immunol; 1977; 21(2):99-110. PubMed ID: 859455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TUBERCULOIMMUNITY INDUCED BY KILLED TUBERCLE BACILLI AND THEIR CONSTITUENTS.
    CROWLE AJ
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:27-34. PubMed ID: 14164134
    [No Abstract]   [Full Text] [Related]  

  • 36. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system.
    De Weger RA; Pels E; Den Otter W
    Immunology; 1982 Nov; 47(3):541-50. PubMed ID: 6215342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the methanol extract residue (MER) tubercle bacillus fraction on the production of antibodies in vitro. II. Effects on macrophage and lymphocyte populations.
    Ben-Efraim S; Halperin D; Reuben C; Dar O; Weiss DW
    Cell Immunol; 1984 Jun; 86(1):33-45. PubMed ID: 6373023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
    Hwang SA; Kruzel ML; Actor JK
    Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The induction by Listeria monocytogenes and plant mitogens of lymphocyte supernatant fluids which inhibit the growth of Mycobacterium tuberculosis within macrophages in vitro.
    Klun CL; Youmans GP
    J Reticuloendothel Soc; 1973 Mar; 13(3):275-85. PubMed ID: 4196703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.